ScholarLens Back to search
2001•Annals of the Rheumatic DiseasesOpen access

Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine

David L. Scott, J S Smolen, J R Kalden, L B A van de Putte, A Larsen, T K Kvien, M Schattenkirchner, P Nash, C Oed, I Loew-Friedrich

Open full text 194 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 194 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Leflunomide, Sulfasalazine, Rheumatoid arthritis, Placebo, Arthritis, Antirheumatic Agents, Internal medicine

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine — Research Paper | ScholarLens